
Kies je etiket
direct zichtbaar op de vialReta + Cagri Blend
GLP-1
- Verzonden vanuit Duitsland
Bestelling
- DHL met tracking
- Discrete verpakking
In één oogopslag
Reta + Cagri Blend in cijfers
De kerncijfers uit ons lexicon.
Volledig lexiconartikel- Class
- Triple agonistGLP-1 / GIP / glucagon, + amylin analog
- Half-life
- Retatrutide around 6 dayscagrilintide around 7 to 8 days
- Form
- Lyophilisatepowder, reconstituted with BAC water
- Sizes
- 30 mg1 size in the shop
What studies show
All 5 sources in the lexicon- up to24.2 %Jastreboff et al., NEJM, 2023
- Sanyal et al., Nature Medicine, 2024
- Lau et al., The Lancet, 2021
Er is nog geen labanalyse voor Reta + Cagri Blend. Stem eropLaat het zelf testen, wij betalen de helftAlle labanalyses
Kennis
Alles over Reta + Cagri Blend
Uitgebreide informatie volgt binnenkort.
Dosering
Doseringsinformatie laden …
Handig om erbij te hebben
Wat je erbij nodig hebt
Bacteriostatisch water wordt automatisch aan je winkelwagen toegevoegd. Spuiten en doekjes met één klik.
Insulinespuiten
10 stuks · 5.50 €
Alcoholdoekjes
50 stuks · 10 €
Hoeveel water?
Eenheden op de spuit voor jouw vialgrootte.
Naar de calculator →Is the Reta + Cagri Blend approved or studied?
No. As of 26 October 2026 the registry ClinicalTrials.gov lists no trial with Retatrutide and cagrilintide together. Both components are in phase 3 and not approved.
Why Retatrutide and cagrilintide together?
Both act on different satiety pathways: Retatrutide on GLP-1, GIP and glucagon, cagrilintide on amylin receptors. With semaglutide as the partner, weight loss in a phase 1b trial after 20 weeks was 17.1 instead of 9.8 percent. For Retatrutide as the partner there are no data.
What do the studies of the components show?
Retatrutide alone: in TRIUMPH-1 after 80 weeks 25.0 percent less body weight on average at the highest study dose, 3.9 percent on placebo. Cagrilintide alone: up to 10.8 percent after 26 weeks in phase 2, 3.0 percent on placebo. In a substudy liver fat also fell sharply on Retatrutide.
Why is the cagrilintide share so small?
The vial contains five times as much Retatrutide as cagrilintide, because Retatrutide is the stronger and limiting part. Anyone going by the Retatrutide share stays far below the amounts used in the cagrilintide trials. Whether the small share contributes anything has not been studied.
How long do the components stay in the body?
Retatrutide had a half-life of about six days in a phase 1b study, cagrilintide 159 to 195 hours in another study, so about a week. Both fit one dose per week.
Which side effects were seen with the components?
With both, mainly gastrointestinal effects such as nausea and diarrhoea, depending on the dose. On Retatrutide heart rate rose in a dose-dependent way in phase 2. Two satiety signals together may strengthen nausea at the start, this has not been measured for this blend.
Which trials are still running?
Nine phase 3 trials of Retatrutide are running, the largest on heart and kidney events until 2029. The RENEW trials of cagrilintide alone run until 2027. No trial of the blend is listed in the registry.
Gerelateerd
Gerelateerde producten
Tirzepatide
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
10 maten
Laboratoriumgetest
= vanaf 10 €/vial
Retatrutide
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
11 maten
Laboratoriumgetest
= vanaf 16 €/vial
Semaglutide
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
6 maten
Laboratoriumgetest
= vanaf 10 €/vial
Mazdutide
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
2 maten
= vanaf 32 €/vial
Reta + Cagri Blend